Print Icon
 
   
   

Do you have emerging oncology innovations that have the potential to improve

diagnosis and treatment of cancer?

   

Dear Customer,

 

Lean Life Science and Cancer Research Horizons are pleased to announce that applications for Oncology Development Programme 2 (ODP2) Part 2 are now open.

 

Part 2 will take place 7 - 9th March and will provide a deep-dive into the highly successful Lean Life Science approach to developing oncology assets and securing investment.  It will provide the opportunity for attendees to engage directly with our LLS partners:  pharma companies, CROs, and oncology experts. 

 

You do not need to have attended Part 1 in order to attend Part 2.

https://campaign-image.eu/zohocampaigns/130766000000341067_zc_v34_1676277074929_part2agenda.jpg

ODP2 will help participants develop their innovations with fully validated, timed, costed, project plans with the right delivery partners. With these vital materials innovators significantly increase their chance of attracting the investment required to enable further development of their innovation toward potential patient benefit.

 

If you think that any of the innovations in your network would benefit from participation in ODP2 please share this information.


Full details of ODP2 can be found here, along with dates of Q&A webinars.


If you have any queries, please do not hesitate to contact either myself or my Executive Assistant, Claire claire@leanlifescience.com 


With kind regards,


-Ned Wakeman

   
   

Follow Us On
   
 
Lean Life Science | 1S32 Alderley Park, Nether Alderley, Macclesfield, England, SK10 4TG